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Throughout history, dengue virus infections have negatively impacted the mission
capabilities of US Service Members. Currently, the expansion of dengue into new
regions via the spread of the Aedes genus along with the global presence of the US
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Military, poses an increased risk for Service Members to contract the virus. Dengue
virus infection would not only lead to significant medical costs and a lack of military
readiness, but to mission impairment and failure. Therefore, it is important that the US
Military explore the virulence, outbreaks, and treatments of dengue virus infection to
help prevent its spread and determine solutions for its eradication. This review
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examines current dengue epidemiology by Combatant Commands, field detection,
treatments, preventive measures, prophylactic capabilities, and directions of future
research.

INTRODUCTION
Dengue virus (DENV) infections have been a cause of illness in military personnel
throughout history with the erosion of mission capabilities and lost duty days being
heavily underestimated. Additionally, the risk of dengue among US Service Members
is increasing, consequently leading to mission impairment and significant costs.
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Corroborating this is a recent study involving 1,000 US Army personnel with a single
deployment to a dengue-endemic region identified 15 Soldiers who developed
antibodies to at least one DENV type [1]. This information demonstrates the need for
increased research of DENV and a more comprehensive understanding of risk factors
associated with vector virus exposure and infection. Dengue is a vector-borne disease
spread through the bite of the mosquito genus Aedes and is endemic in more than 120
countries causing upwards of 390 million diagnosed infections a year [2,3]. There is a
high likelihood that US Service Members (Army, Marines, Navy, Air force, and Coast
Guard) will encounter the virus at some point in their careers. Therefore, as an issue of
military readiness, it is important that the military explore the virulence, treatments,
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outbreaks, and other traits of dengue to determine the best future actions to prevent
the spread of the disease as well as solutions to eradicate the disease altogether.
There are four DENV serotypes (DENV-1, DENV-2, DENV-3, and DENV-4) all of which
cause a range of symptoms depending on the individual infected. The manifestations
of dengue range from an asymptomatic infection or mild fever to hemorrhagic fever
and dengue shock syndrome [3]. Further, if an individual is exposed to one of the
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serotypes and recovers from an infection, but is subsequently

antibody within this antibody-virus complex then attaches to

re-exposed

for

circulating receptors on monocytes and allows the virus to infect

exacerbated illness increase. The US Military operates

the monocytes. The resulting monocyte infection is associated

globally, and therefore, Service Members are deployed to

with an increase in virus replication and a higher risk of severe

many DENV endemic regions. Thus, analysis of the detection

dengue disease [4]. Therefore, the elicitation of broadly

and treatment methods of a DENV infection is imperative to

neutralizing antibodies present alluring targets for vaccine

understand so that military medicine and medical policy

discovery [2]. Broadly neutralizing antibodies recognize all

reflects how best to address this viral disease. This review

four DENV serotypes, thereby destroying the virus instead of

examines current epidemiology by Combatant Commands,

promoting virus uptake into the cell. The cell and organ tropism

field detection, and treatments for dengue in order to establish

of DENV can explain disease symptoms and impact infection

the military’s baseline diagnostics, preventive measures, and

severity. Although cell and organ tropisms have been best

prophylactic capabilities and to project the direction of future

studied through animal models, to date, the murine and non-

research.

human primate models are not considered acceptable

MATERIALS AND METHODS

representations of viral replication and disease manifestation

For the purpose of this review, the information presented about

in humans [6]. Furthermore, clinical autopsies investigating viral

DENV and its infection was limited to reports conducted within

tropism are limited despite the large number of confirmed

the last ten years (2009-present) due to the dramatic growth in

infections, which is believed to be due to the remote locations

incidence of dengue worldwide in the recent decade [4].

of where many of these fatal cases occur [6]. Thus, the limited

Moreover, this review organizes DENV outbreaks and studies

studies and clinical data collected identify three predominant

by US Military Combatant Commands (geographic and

organ systems associated with DENV infection: the immune

functional) to better facilitate military missions, functions, and

system, the liver and endothelial cells. Within the immune

planning. Examples of internet search words used for this

system, infected dendritic cells responding to a mosquito bite

review were “dengue virus,” “military,” and “outbreaks” on

site inadvertently transport DENV to lymph nodes where they

Google, Bing, and PubMed. Only peer-reviewed and fully

amplify and spread infection to blood-derived monocytes,

accessible articles were reviewed to ensure that the discoveries

myeloid dendritic cells, and splenic and liver macrophages [6].

and information presented are current and thorough.

The liver is a commonly noted viral target in severe murine,

RESULTS

non-human primates, and human DENV infections. DENV is

to

another

serotype,

his/her

chances

Dengue and its Health Consequences
Dengue is caused by four antigenically distinct, single-stranded,
positive-polarity RNA viruses, identified as dengue virus
(DENV-1 through 4), denoting the various serotypes of the virus
[5]. A serotype is a distinct variation of a virus which contains
varying virulence factors, and the prevalence of serotypes
varies by geographic region. Being infected by one serotype
leads to lifelong protection from that serotype; however, a
secondary infection with a different serotype increases the risk
of severe dengue manifestation [2]. This phenomenon is known
as an antibody-dependent enhancement (ADE) of infection. In
ADE, preexisting antibodies from the first DENV infection bind
to the second DENV serotype virion particles. Rather than
neutralizing the viral infection threat, the antibody merely
attaches to new viral particles produced after infection. The

present in high viral loads within human hepatocytes and
Kupffer cells and is responsible for observed apoptosis,
necrosis, and the eventual development of coagulopathy, or the
absence

of

blood

clotting

[6].

The

development

of

coagulopathy and plasma leakage is thought to be further
amplified with the infection of endothelial cells [6]. However,
the role of endothelial cells remains controversial with the
limitations of current study models. DENV infections present a
broad spectrum of symptoms, ranging from asymptomatic to
undifferentiated fever, Dengue Fever, Dengue Hemorrhagic
Fever (DHF), or Dengue Shock Syndrome (DSS) (Figure 1) [7].
Dengue fever is characterized by incapacitating symptoms of
fever,

severe

headache,

myalgia,

arthralgia,

and

gastrointestinal discomfort [5,6]. Symptoms manifest in two
phases with the first phase of illness occurring 3-8 days after
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Figure 1: Symptoms of dengue virus infection. Dengue is difficult to clinically identify given the variability in the
manifestations associated with infection. However, the World Health Organization (WHO) has outlined a
general classification system with respect to dengue virus infection. This figure is adapted from dengue
hemorrhagic fever: diagnosis, treatment, prevention and control. 2nd edition. Geneva: World Health
Organization.
the mosquito bite, and the second phase of illness occurring

within each of the Combatant Commands addressed below, the

after a period of improvement. The second phase can be

estimates of DENV infection cases are underreported signifying

followed by reappearance of fever and development of

that the military must be wary of the severity of the occurring

measles-like-rash, generalized lymphadenopathy, and minor

outbreaks. Overall, identifying and learning from these

hemorrhagic phenomena [5]. The categorically more severe

outbreaks will help the US Military face the threat and take

cases of DHF present all symptoms of dengue fever, but also

preventive measure to address DENV infection globally.

express hemorrhagic manifestations and plasma leakage.

Indo-pacific

Hemorrhagic manifestations encompass bleeding in the skin

outbreaks have been occurring intermittently in the Pacific

and gastrointestinal tract. The gravest DENV symptom

region, and in 2012 for the first time, the Pacific region

classification, DSS, is reached once shock sets in, and without

registered a high prevalence of all four serotypes of DENV [8].

treatment intervention, becomes fatal within 12 to 36 hours [5].

In 2014, Taiwan experienced its largest dengue fever

Annually, there are 100 million cases of dengue fever and half

outbreak, with 15,372 cases reported [9]. The heterogeneity in

a million cases of DHF. While DENV serotype has no

DENV seroprevalence within a single metropolis during this

correlation on disease classification, greater severity cases

outbreak was a source of concern due to current vaccines

trend in children and the elderly.

against DENV having low efficacy and to the potential to

Dengue Outbreaks within Combatant Commands

enhance the disease with the mixing of different serotypes [9].

Since the U.S. Military operates within the construct of

Also, in 2014, 131 DENV infection cases were reported in

Combatant Commands, it is necessary to understand how and

Yoyogi Park located in Japan [10]. It should also be noted that

where DENV infection is in relation to operations to

during the past 10 years there appears to be little dengue

appropriately assess and control risk (Figure 2). The following

incidence in Korea and China, both of geopolitical interest,

sections are divided into DENV infection outbreaks specifically

perhaps due to some environment and climate factors related

within geographic commands and one functional command to

to the Aedes genus (Figure 2).

command

(INDOPACOM):

Dengue

provide clarity of the threat posed. It should be noted that
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Figure 2: Global dengue risk assessed by geographic Combatant Command. Special Operations Command
(SOCOM) operations occur in all five geographic Combatant Commands. The underlying map was adapted
from Figure 1 of Simmons CP, Farrar JJ, van Vinh Chau N, Wills B. Dengue. New England Journal of
Medicine. 2012; 366(15):1423-1432. The colors signify suitability for dengue transmission with red being
high suitability all the way down to blue for low suitability. The grey signifies non-endemic
regions/unsuitable for dengue transmission.
Southern command (SOUTHCOM): In Central America,

26,766 cases and 148 fatalities, the greatest number ever

multiple countries have experienced DENV infection epidemics.

recorded [11]. Among these infections, DENV-1 was the most

Dengue is known to be persistent in the jungle areas, with

prevalent. Adults consistently represent roughly one-half of the

epidemics frequent in the wettest months, and subsequently

reported cases [13]. The Passive Dengue Surveillance System

imported into the coastal regions, especially during times when

(PDSS) currently monitors DENV infection in Puerto Rico, to

environmental

mosquito

include the early detection of the virus to enable timely

breeding [11]. This phenomenon was seen in Peru in 2001, with

intervention and evaluate programs to prevent and control

137 confirmed cases in the province of Trujillo.

dengue [13]. Although the information gathered through PDSS

Brazil has experienced dengue outbreaks since 1845, but the

is helpful towards accumulating data, it does not help control

current situation is alarming. Due to the tropical climate of

this virus. Studies show that for each case of dengue reported

Brazil, the country is susceptible to the circulation of arboviruses

to the PDSS, an additional 10-27 cases were not reported

such as DENV across its states [12]. In 2013, there were a total

[13].

of 1,468,873 reported DENV infection cases, of which 6,969

Africa command (AFRICOM): Studies show that a better

were severe (DHF and DSS) cases with 545 deaths [12].

surveillance and diagnosis system for dengue is necessary due

However in 2014, there was a 39% decrease in mortality

to the prevalence of DENV infection in Africa, yet these

rates. In 2015, the Brazilian Ministry of Health registered

countries are still struggling to implement an effective system

1,254,907 cases, which was an increase compared to that of

despite the rising number of cases. Sero-epidemiological

2014. Not only is DENV circulating on the continent, there has

surveys have demonstrated that DENV infection is widespread

been circulation of all four serotypes reported in the Hispanic

in Nigeria, yet there is little information on dengue fever and

Caribbean Islands. Additionally, while not formally part of

little attention paid to DENV infection overall because it

Southern Command, DENV-2 has circulated continuously in

presents as a classical fever with the main misdiagnosis of the

Puerto Rico for 25 years, including an outbreak in 2007 and a

disease being malaria [14]. This highlights the need for African

prolonged epidemic in 2010. During this epidemic, there were

countries to enhance the capacity of laboratories to diagnose

conditions

sustained

year-round
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DENV infection correctly with modern equipment and new

populations in regions where it was not previously endemic.

infrastructure. Another study conducted in various urban centers

This, coupled with climate change leading to vector migration

of the rainforest region of Nigeria found an overall DENV

of mosquitoes northward into the US, could spark a potential

infection prevalence of 23.4% with the highest monthly

outbreak in the near future. Since DENV can travel within

prevalence of 40% in April and August [15]. The monthly

infected mosquitoes from one continent to the next, the US

differences indicate efficient virus transmission from mosquitoes

Military must be wary and account for possible outbreaks of

to humans during these times and show that routine diagnosis

DENV infection in regions not normally endemic to the virus.

for DENV infection is necessary [15]. In Djibouti, the first

Special operations command (SOCOM): Although not a

epidemic of DENV-3 was reported in a study by the French

geographic Combatant Command, Service Members within

Armed Forces Health Service between 2011 and 2014 [16].

SOCOM are at increased risk of exposure to DENV infection

Of the 354 suspected cases of DENV infection, 128 confirmed

based on their multiple deployments to endemic regions of the

cases were discovered and demonstrated the circulation of

world. These repeated deployments increase their risk not only

DENV-1, -2, and -3 in all hospitalized patients in the study

of contracting dengue fever, but of developing more serious

[16]. At the Malindi District Hospital in Kenya, DENV infection

manifestations of the disease to include DHF and DSS. To

outbreaks in 2017 were associated with the DENV-2 serotype.

highlight the seriousness of DENV exposure to SOCOM forces,

However, the strains isolated from 10 different patients were

a two-part study was conducted 2012-2014 examining

all quite different [17]. Thus, as potential new serotypes start

baseline exposure to DENV in 500 de-identified SOCOM

to emerge in African countries, it raises the concern for the

Service Members as well as the exposure rate of 414 de-

prevalence and severity of dengue outbreaks due to ADE.

identified SOCOM Service Members based on pre- and post-

Additionally, it highlights the need for an easily identifiable

deployment sera. The first part of the study concluded that 48

way to detect not just one DENV serotype, but the creation of a

out of 500 (9.6%) specimens exhibited a baseline DENV

diagnostic and treatment plan that covers all four serotypes.

exposure rate from all the missions preformed throughout

Central command (CENTCOM): Within CENTCOM, in 2016

endemic regions [23]. The second part of the study showed that

there were dengue outbreaks in Yemen and Saudi Arabia.

55 of 414 (13.2%) specimens were seropositive to DENV only

Dengue is not known to be endemic in the western and southern

after deployment to AFRICOM, INDOPACOM, SOUTHCOM, or

regions of Saudi Arabia, so this outbreak caused great concern

Central America [23]. Since SOCOM Service Members operate

[18]. Although there is lower burden of DENV infection in the

in small teams, an exposure rate as high as 10% can cause

Middle East and North Africa than Asia, it cannot be

mission failure.

discounted within this Combatant Command because antibodies

Difficulties Diagnosing DENV Infection in the Field

to DENV were detected in nationals from countries within

Four roles of medical care exist in regard to the US Military

CENTCOM, supporting the need to better understand the

field environment [24]. (Table 1) summarizes the functions and

regional epidemiology of dengue [19].

location of each particular role as it pertains specifically to the

European command (eucom) and northern command

Army (main ground force). As depicted, Role I is the first

(NORTHCOM): DENV is not known to be endemic within

responder with unit level care, and it resides far-forward on

EUCOM. Thus far, there have only been singular and isolated

the battlefield with the Soldier and at battalion aid stations.

DENV infection cases in EUCOM, with no disease spread or

Role II is forward resuscitative care residing at medical

outbreaks [8,20,21]. However, there is a clear presence of

companies within forward operating bases and has the function

dengue in Mexico and the Caribbean Islands leading to cases

of treating trauma after the Role I immediate measures. Role III

of DENV infection in the US, specifically in Florida due to its

is theater hospitalization and resides at the established combat

close proximity to the Caribbean [22]. An influx of dengue

support hospital(s) and medical treatment centers in the country

infected migrant workers and immigrants into susceptible Aedes

of operation. Finally, Role IV is definitive care residing at

populations are a way dengue could travel to infect

permanent base hospitals located around the world. To combat
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Table 1: Roles of medical care within the US Army.
Role I
MAIN ROLE:
• Unit-level medical care
• Immediate life saving measures
WHO:
• Combat medics
• Self-aid and buddy aid
• Combat Lifesaver
• Special Forces Medical Sergeant
(l8D)
• Medical technicians
CAPABILITIES:
• Disease /non-battle injury
prevention and care
• Combat operational stress
prevention
• Primary healthcare, routine sick
call
• First aid and triage
• Resuscitation and stabilization
• Casualty collection and
evacuation preparation
WHERE:
• Within the unit /on battlefield
LIMITATIONS:
• Holding patients
• Healing serious injury or illness

Role II
MAIN ROLE:
• Advanced trauma and
Management emergency medical
treatment
WHO:
• Role 2 Light Maneuver (2LM):
• Mobile medical units
• Conduct advanced resuscitation
up to damage control surgery
• Prepare for Role 3 and 4
• Role 2 Enhanced (2EN):
• Basic secondary healthcare
• Stabilize post-surgical cases for
evacuation straight to Role 4
CAPABILITIES:
• Carry packed blood products
• Limited x-rays
• Laboratory access
• Dental support
• Combat/operational stress control
• PVTMED
WHERE:
• Within the unit/FOB
LIMITATIONS:
• Holding many patients
• Holding for more than 72 hours

Role III
MAIN ROLE:
• Providing support to units without
organic medical assets
• Caring for patients in medical
treatment facility (MTF) with proper
staff and equipment
WHO:
• Physicians/physician assistant
• Medical personnel in MTF
CAPABILITIES:
• Resuscitation
• Initial wound surgery
• Specialty surgery
• Post-op treatment
• Evacuating patients from supported
units
• Physical therapy
• Holding 200+ patients
• Pharmacy access
• Nutrition consultation
WHERE:
• Medical treatment facility

Role IV
MAIN ROLE:
• Most definitive medical care in
military health system
WHO:
• Physicians/physician assistants
• Medical personnel in hospital
• Department of Veterans Affair-,
CAPABILITIES:
• Post-op rehabilitation
• Significant/life-threatening
surgeries
• Advanced equipment access
• Usage of CONUS and civilian
Hospitals
WHERE:
• CONUS in base hospitals or
robust overseas facilities

This table was extracted from Cubano, M. A., & Butler, F. K. (2018). Emergency War Surgery. (pp. 19-22). Fort Sam Houston, TX: Borden Institute, US Army Medical
Department Center and School, Health Readiness Centre of Excellence, Fort Sam Houston, Texas, Office of The Surgeon General, United States Army.

Figure 3: The Next Generation Diagnostics System Increment 1 (NGDS-1), also
known as the Bio Fire Film Array® 2.0. This figure was extracted from Next
Generation Diagnostics System, Increment 1 Fact Sheet, 7/27/2017. Point of
Contact: Chemical, Biological, Radiological, & Nuclear Information Resource Center
(CBRN IRC), CBRN.IRC@mail.mil, Toll Free: 18008314408, Commercial: (309)
7827349, DSN: 7937349, Fax: (309) 7821919.
disease symptoms associated with DENV infection in the field, timely identification of US Service Members infected with DENV
provides for “rapid and appropriate patient management decisions” such as supportive care therapies and medical evacuation
[25]. Identification and diagnosis of DENV infection within Service Members has been done in the last 20 years with the use
Polymerase Chain Reaction (PCR) technology. The “Ruggedized” Advanced Pathogen Identification Device (RAPID) PCR platform
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was used to identify DENV early on. When a dry-format PCR

this article) were recommended as potential far-forward

assay was performed on this device, the assay demonstrated

diagnostics. This same study suggests that diagnostics in fixed

100% analytical specificity for detecting DENV. Both human

hospitals (Role 3) do not need to be as portable as those far-

and mosquito samples were tested in austere field conditions

forward, but must be very accurate to inform patient care

where the RAPID system was set up in six hours in open air

decisions [31]. Hence, the NGDS-1 will fill this capability gap

locations and operated using a generator or a car battery

as soon as the Global Fever Panel is available for use on it.

[25]. Results of this system, including the set up mentioned

However, clear guidelines for dealing with a positive or

above, took anywhere from 2-4 days to accurately identify the

negative result are currently being formulated to establish

agent of interest. The RAPID system was replaced by BioFire’s

clear courses of action for identified DENV infection [31]. At

Joint Biological Agent Identification and Diagnostic System

Role 4, DENV infection diagnosis is performed usually with host

(JBAIDS), which was designed to improve upon the RAPID

nation assistance, by commercial diagnostic companies, or by

system by increasing the accuracy and speed of biological

other facilities using PCR assays on various platforms [31]. This

warfare agent detection and identification [26]. The JBAIDS

Role 4 diagnosis process is concerning in that this has reduced

was able to fit into a rucksack and perform agent

reliability both in speed and in receiving the results, which is

detection/identification on location with electricity in about 40

why having diagnostic capabilities at Role 3 is imperative.

minutes with 85-90% accuracy [27]. The Joint Program

Within the US Military, medical evacuation decisions are

Executive Office – Chemical, Biological, Radiological, and

executed prominently on symptom-based medicine at Roles 1

Nuclear Defense (JPEO-CBRND) Medical Countermeasure

to 3 when diagnostics are unavailable. For DENV infection,

Systems (MCS) fielded approximately 350 JBAIDS to the Joint

identification of it can be quite challenging compared to other

Services over its lifecycle. A DENV assay was available for use

febrile illnesses meaning that some cases of DENV infection that

on the JBAIDS PCR platform; however, BioFire is no longer

lead to DHF are missed [31]. Furthermore, antibiotics are

making systems or assays, and by 2020 the JBAIDS will no

sometimes inappropriately prescribed when the diagnosis is

longer be operational [28]. The Next Generation Diagnostics

incorrectly assigned as bacterial instead of virus [31].

System Increment 1 (NGDS-1), also known as the BioFire

Therefore, it is important for the military to consider the effects

FilmArray®

2.0 (Figure 3), will replace the JBAIDS one-for-one,

of DENV infection and integrate new equipment and measures

and offer a simple, portable PCR platform to aid the diagnosis

to provide the most efficient and greatest amount of care while

of both clinical and environmental samples [29]. JPEO-CBDND

minimizing the cost and mission capability losses.

MCS has completed fielding of NDGS-1 to the Air Force

Preventive Measures - Vector Control and Surveillance

environmental and diagnostics users and is planning to field to

Due to the absence of vaccine treatments and licensed

the Army (Role 3) and Navy users as well [29]. The NGDS-1

prophylactics for DENV infection, the US Military must utilize

Infectious Disease Panel (also called the Global Fever Panel)

preventive measures such as vector control and surveillance to

does detect dengue. This is still in advanced development

limit personnel risk. Thus, vector control is the main way the

awaiting FDA approval [30]. Currently, there are no Food and

military is combating dengue. A key tenet of military vector

Drug Administration (FDA) compliant diagnostics for DENV

control operations with respect to dengue is not only diminishing

infection at Roles 1, 2, or 3. Accordingly, a 2016 study on

the number of potential mosquito vectors, but decreasing

assessing the diagnosis capability gap of DENV in the military

transmission of DENV to military personnel [32]. The vector

health system concluded that any diagnostic tests used at far-

control technique of reducing contact is primarily used when in

forward locations (Roles 1 and 2) need to be rugged, simple to

endemic areas. In line with this, Service Members should be

operate, and used primarily to inform medical evacuation

required to sleep with a mosquito net within dengue endemic

decisions [31]. Antigen-antibody based detection assays similar

regions. Second, units should choose field positions away from

to those used for vector pathogen detection (discussed later in

standing water to avoid potential mosquito breeding centers.
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Figure 4: Arthropod Vector – Rapid Detection Devices (AV-RDDs), better known
as “dipstick” tests, come in kits that contain sample holding tubes, grinding tools
and the buffer solutions necessary to run the test. The AV-RDD targets
arthropod-borne diseases, a primary readiness threat to warfighters. Photo
taken by LTC Vanessa R. Melanson and published in Reference 34.
These two techniques used in combination with chemical control

throughout the environment and are very focal [32]. The

methods such as insecticides and larvicides can prevent DENV

distribution of vector-borne pathogens such as dengue in a

infection. With the addition of permethrin-treated uniforms and

given environment reflects many factors to include the

chemical insect repellants, a DENV infection is preemptively

mosquito’s ability to effectively transmit DENV as well as the

combated to protect military personnel [25]. Along with the

presence of appropriate environmental conditions. However, it

vector control methods of reducing contact and chemical

must be understood that the presence of a potential vector such

controls, biological control methods have been focused on

as the Aedes mosquito alone is not always indicative of risk of

effectively reducing DENV transmission in areas where the risk

disease; therefore, surveillance is key to monitoring the disease

to deployed military forces is greatest. Interventions are being

threat to military personnel. A wide variety of methods are

developed to include reducing the mosquito population by

currently used for vector surveillance. The different methods

manipulation of female mosquito behavior as well as replacing

vary greatly in the amount of training required, logistical

endogenous DENV infected mosquitoes with ones that are

support, sample throughput, and ability to be conducted in an

unable to transmit the virus [33]. Some courses of action to

operational setting. The selection of the method whether

address the mosquito population include introducing male

baseline, operational, or specific surveys depends on the

mosquitoes with Wolbachia bacteria, which renders them

specific objective of the surveillance [32]. One method in use,

reproductively

engineering

aligning with specific surveys and done for approximately the

mosquitoes that need a drug added to their larval diet to

last 5 years for dengue surveillance, is mosquito vector testing

survive [33]. It is important to note that vector-borne pathogens

through Vector Pathogen Detection (VPD). VPD provides

such as DENV are not uniformly or randomly distributed

military medical professionals with the necessary information to

incompatible

or

genetically
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implement very specific disease and vector control measures

platelet count at both 40 and 48 hours after treatment than the

[32,34]. VPD can minimize dengue disease transmission by

control group of 117 patients. Ultimately, this study found that

sampling mosquitoes before human transmission occurs, thereby

the arachidonate 12-lipoxygenase and Platelet Activating

decreasing the health impacts on military operations. Military

Factor Receptor genes were expressed by the patients who

VPD is done in different ways, depending on the battlefield

had been taking the juice for three days indicating that the

location. To detect potential dengue infected mosquitoes in a

Carica papaya juice did help raise the platelet counts [39]. Both

specific area of operation, two different types of biochemical

of these studies suggest that including papaya into a

assays can be performed. One type is that of an

supportive care regiment for DENV infected patients will help

immunological or “dip-stick” assay, which is based on antigen-

them recover faster.

antibody interactions. The assay specific for DENV detection in

Vaccine development: Vaccine development is crucial to

mosquitoes is known as the Dengue Virus Arthropod Vector

prevent the contraction of DENV from mosquitoes and to

Rapid Detection Device (AV-RDD). It is relatively easy to

protect the US Service Members abroad. Developing a vaccine

perform and to interpret because it relies on visual assessment

to prevent DENV infection is challenging because of the many

for determination of positive or negative results (Figure 4) [32-

serotypes. Vaccines, therefore, must be able to induce

35]. This assay can be done with the use of minimal equipment.

serotype-specific responses for each of the four. Consequently,

The second type of assay for VPD is PCR based. DENV specific

to be truly protected against DENV infection, an individual

PCR assays have been developed by the services for

either needs to receive a vaccine adequate to address all

application on the JBAIDS, and conversely, with JBAIDS DENV

serotypes or multiple vaccines each aimed at a specific

assay available for use on mosquitoes [36,37].

serotype. A vaccine that only addresses one of the serotypes

Prophylactics

can have disastrous effects as the disease could increase the

The current standard of treatment for DENV infection is

severity of disease via ADE if infected by a different serotype

supportive care. The infected individual should get plenty of

[40]. Thus, several vaccines that have been developed, while

rest,

as

others are in beginning research phases, all aiming to address

acetaminophen. Even when this treatment regiment is followed,

the complex nature of DENV infection. To create a successful

it takes approximately a week to recover if the dengue fever

DENV vaccine, researchers have tried to use vaccines

does not progress into DHF or DSS. Thus, alternate supportive

previously developed to viruses similar to it. For example, the

care treatments as well as vaccines and drugs are in

chimeric yellow fever dengue tetravalent vaccine was one of

development and testing to address treating DENV infection

the first vaccines developed, which is also called Dengvaxia

symptoms.

[41]. This live attenuated vaccine was shown to elicit

Alternative supportive care: Two recent studies have

neutralizing antibodies after three doses, yet these antibodies

examined natural ways to treat DENV infection. A Malaysian

had low effectiveness against DENV-1 and 2 [42].

study conducted with 306 patients noted that 85.3% used

Other potential live attenuated chimeric vaccines created to

complementary alternative medicines [38]. The top alternative

address DENV are the TV003/TV005 vaccine and the

treatments were all various diet changes including isotonic

Tetravalent Dengue Vaccine (TDV) [41]. The TV003 vaccine

drinks, crab soup, papaya leaf extract, coconut juice, and

developed by the National Institute of Allergy and Infectious

watermelon [38]. Since this study aimed to understand the

Diseases and the National Institute of Health was promising at

types, reasons, and prevalence of alternative treatments for

first, but it too had a weak seroconversion against DENV-2

DF, a recommendation of which treatment(s) works best was not

[41]. Perhaps the most promising vaccine is the TDV vaccine.

proposed. However, another Malaysian study tested the

Phase 2 of the clinical trials of the TDV vaccine showed

effects of the papaya leaf extract [39]. During the study, the

inducement of antibodies against all four serotypes and is

intervention group of 111 patients who received the papaya

currently in Phase 3 where it will enroll 20,000 children to

extract in the form of juice had a significantly higher mean

determine the efficacy of the vaccine [41]. While showing

drink

fluids,

and

take

pain

relievers

such

09
Combating Dengue: A US Military Perspective. Virology & Retrovirology Journal. 2019; 2(2):123.

Virology & Retrovirology Journal
potential to induce immune protection against many of the

showed the internalization of these complexes into myeloid

DENV

have

cells was also dependent on pH and dynamin; however, the

difficulty protecting against all of them. This may be due to the

requirement of clathrin-mediated endocytic route depended on

unbalanced replication of vaccine viral strains when using an

the receptors involved in the complex uptake [3]. Therefore,

attenuated virus [40]. Another possibility for developing an

DENV entry into myeloid cells in the absence or presence of

efficient DENV vaccine is to use the envelope protein in a

antibody can be blocked by diverse biochemical inhibitors

protein-subunit vaccine [40]. Using the envelope protein as the

affecting the cellular factors involved in endocytosis [3]. For this

viral

reason, specific biochemical inhibitors may be the key to

serotypes,

antigen

attenuated

paired

with

tetravalent

vaccines

polylactic-co-glycolic

acid

nanoparticles has been shown to induce enhanced immune

creating a drug to block endocytosis of the virus.

responses in both monovalent and tetravalent forms. Also, the

CONCLUSION

technique of nanoparticle attachments has helped create

It is estimated that more than 3 billion people living in more

balanced serotype specific immune antibody responses to each

than 120 countries are at risk of DENV infection and

DENV serotype [40]. This nanoparticle vaccine platform can be

approximately 390 million DENV infections occur annually [9].

a promising alternative in discovering a vaccine for not only

Dengue is highly prevalent in tropical countries due to climate,

DENV but also West Nile, yellow fever, and Zika viruses [40].

population

Drug development: Currently, there is no available drug to

increased travel and trade [43]. As such, prevention of DENV

stop the pathogenicity of DENV. However, a few possible drug

infection and other vector-borne diseases should be a health

compounds have been tested in clinical trials. Examples of

priority

these

and

INDOPACOM and SOUTHCOM. All subordinate leaders should

celgosivir [42]. None of these drugs successfully reduced or

also understand the risk to their personnel’s health and ensure

prevented

[42].

that the appropriate vector control and surveillance measures

Corticosteroids and lovastatin are two additional drugs that

are enacted to best achieve mission accomplishment especially

were used at one time to treat dengue fever. Both were tested

since, there are no currently approved dengue diagnostics

in clinical trials, and while corticosteroids showed no efficacy

available far-forward on the battlefield.

against DENV infection, lovastatin did inhibit replication in vitro

ACKNOWLEDGEMENTS

compounds

include

symptoms

of

chloroquine,
spread

of

balapiravir,
the

virus

[42]. Like the development of the DENV vaccine, more
treatment is needed to evaluate the true efficacy of these
potential drugs.
Future drug development: Because there is no vaccine or drug
currently used to prevent or treat DENV infection, research is
still fervently ongoing in these areas. With respect to future
drug development, research into specific biochemical inhibitors
should ensue. A recent study examined the interaction between

were established with the formation of immune complexes, and
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